Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtre
1.
Indian J Ophthalmol ; 2012 Jul-Aug; 60(4): 326-328
Article Dans Anglais | IMSEAR | ID: sea-144865

Résumé

Periocular infantile capillary hemangiomas do not always respond well to conventional treatment modalities such as systemic or intralesional corticosteroids, radiotherapy or debulking surgery. The authors describe the use of intralesional bleomycin injections (IBIs) to treat potentially amblyogenic lesions in two cases where other modalities have failed. In both cases monthly IBIs successfully cleared the visual axis of the affected eye before the age of 1 year thus preventing permanent sensory deprivation amblyopia. A total of five and nine injections, respectively, were used and no significant side effects were noted. IBI appears to be a useful alternative in the treatment of periocular capillary hemangiomas refractory to more conventional modalities.


Sujets)
Amblyopie/prévention et contrôle , Bléomycine/administration et posologie , Femelle , Hémangiome capillaire/traitement médicamenteux , Hémangiome capillaire/thérapie , Humains , Nouveau-né , Injections intralésionnelles/administration et posologie
2.
Arq. bras. oftalmol ; 74(3): 207-208, May-June 2011. ilus
Article Dans Anglais | LILACS | ID: lil-598316

Résumé

Hemangiomas are the most common benign tumors of infancy. Despite their self-limited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects.


Hemangiomas são os tumores benignos mais comuns durante o primeiro ano de vida. Apesar do seu curso autolimitado, os hemangiomas capilares podem prejudicar funções vitais ou sensoriais como a visão e causar alteração estética. O tratamento usual inclui esteróides orais ou intralesionais, interferon alfa, citotoxinas, laser e ressecção cirúrgica. Entretanto estes tratamentos não estão livres de complicações e efeitos adversos. Este relato descreve o caso de um bebê feminino de 3 meses com um hemangioma rapidamente progressivo na pálpebra superior esquerda, causando obstrução no eixo visual. O hemangioma respondeu rapidamente a uma baixa dose oral de propranolol. A resposta clínica foi notada poucos dias após o início do tratamento, com regressão a 1/4 do seu tamanho original após 45 dias de tratamento, e a menos de 1/10 após 8 meses, sem ter apresentado nenhum efeito adverso.


Sujets)
Femelle , Humains , Nourrisson , Antagonistes bêta-adrénergiques/usage thérapeutique , Tumeurs de la paupière/traitement médicamenteux , Hémangiome capillaire/traitement médicamenteux , Syndromes néoplasiques héréditaires/traitement médicamenteux , Propranolol/usage thérapeutique , Chimiothérapie d'induction/méthodes , Résultat thérapeutique
4.
MEAJO-Middle East African Journal of Ophthalmology. 2010; 17 (2): 121-128
Dans Anglais | IMEMR | ID: emr-98932

Résumé

Capillary hemangiomas are the most common periocular and orbital tumors of childhood that typically arise in infancy. Though the diagnosis is frequently made on clinical examination, various diagnostic modalities may be helpful in initial evaluation and follow-up. Tests may be necessary in diagnosing suspect cases or aid in the differentiation of potential malignant tumors. In the vast majority of cases these tumors undergo spontaneous involution without sequelae. However, some periocular and orbital capillary hemangiomas require intervention to prevent serious complications. Other tumors require treatment to lessen the surgical burden for cosmetic repair. When treatment is necessary, there are a number of therapeutic options available. As there is no standard, potential risks and benefits must be discussed with the family and treatment should be specific in each case. A complete understanding of the natural history of the tumor, indications for treatment, and response to different therapies is imperative in managing this common lesion


Sujets)
Humains , Hémangiome capillaire/thérapie , Hémangiome capillaire/chirurgie , Hémangiome capillaire/traitement médicamenteux , Amblyopie , Biopsie
5.
MEAJO-Middle East African Journal of Ophthalmology. 2010; 17 (1): 100-102
Dans Anglais | IMEMR | ID: emr-98340

Résumé

Intralesional injection of corticosteroids has been used successfully in the treatment of adenexal hemangiomas, with advantages of easy administration, rapid action, repeatability, efficacy and safety. We report a case of an eight-month-old female infant who underwent intralesional corticosteroid injection for capillary hemangioma that had resulted in amblyopia of her left eye from ptosis. Two weeks after the injection, the hemangioma showed some regression but at that point iris depigmentation of the affected eye was noted. The iris depigmentation remained unchanged during her follow-up visit with significant regression of the hemangioma, associated ptosis and astigmatism


Sujets)
Humains , Femelle , Nourrisson , Injections intralésionnelles/effets indésirables , Hormones corticosurrénaliennes/effets indésirables , Épithélium pigmentaire de l'oeil , Hémangiome capillaire/traitement médicamenteux
6.
Annals of King Edward Medical College. 2006; 12 (3): 471-473
Dans Anglais | IMEMR | ID: emr-75923

Résumé

To report the result of Intralesional steroids [Triamcinolone acetonide 40mg] in case of capillary haemangioma of upper and lower lids. Cosmetically and visually results were excellent, as it is evident from photographs. Intralesional injection of Triamcinolone acetonide 40 mg alone is sufficient to control large capillary haemangioma


Sujets)
Humains , Femelle , Tumeurs de la paupière , Hémangiome capillaire/traitement médicamenteux , Injections intralésionnelles , Triamcinolone/administration et posologie , Triamcinolone
SÉLECTION CITATIONS
Détails de la recherche